GENMAB A/S (GNMSF:OTCMKTS)

$249 -0.45 (-0.1804%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 66

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed GENMAB A/S (GNMSF:OTCMKTS) News Sources

Genmab (CPSE:GMAB) Valuation Check After Recent Share Price Softness And 24.6% Undervaluation Estimate

17-05-2026

yahoo.com

Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress

21-05-2026

yahoo.com

Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons

29-05-2026

yahoo.com

Truist Assigns Buy Rating to Genmab (GMAB)

05-06-2026

yahoo.com

Genmab Presents EPCORE® FL-1 Subgroup Data Demonstrating Consistent Efficacy and Safety Results for Epcoritamab in Combination with Rituximab and Lenalidomide (R2) Across Relapsed or Refractory (R/R) Follicular Lymphoma (FL) Patients

11-06-2026

yahoo.com

Grant of Restricted Stock Units and Warrants to Employees in Genmab

11-06-2026

yahoo.com

Genmab Announces Epcoritamab Monotherapy and Epcoritamab-Based Combination Regimens Demonstrate High Response Rates in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

13-06-2026

yahoo.com

Genmab’s EPCORE Data Deepens Lymphoma Profile As Investors Weigh Upside

15-06-2026

yahoo.com

Major Shareholder Announcement

15-06-2026

yahoo.com

Capital Increase in Genmab as a Result of Employee Warrant Exercise

16-06-2026

yahoo.com

GENMAB A/S (GNMSF:OTCMKTS) Sentiment Trend

0 25 50 75 100 67 79 50 86 73 56 54 83 60 55 17-05-2026 21-05-2026 29-05-2026 05-06-2026 11-06-2026 13-06-2026 15-06-2026 16-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

GENMAB A/S (GNMSF:OTCMKTS) FAQs

toggle

What is the current price of GENMAB A/S (GNMSF:OTCMKTS)?

The current price of GENMAB A/S (GNMSF:OTCMKTS) is $249.


toggle

GENMAB A/S (GNMSF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of GENMAB A/S (GNMSF:OTCMKTS) since the previous trading day is $-0.45.


toggle

GENMAB A/S (GNMSF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of GENMAB A/S (GNMSF:OTCMKTS) since the previous trading day is -0.1804%.


toggle

What is the most recent average sentiment score for GENMAB A/S (GNMSF:OTCMKTS)?

The most recent average sentiment score for GENMAB A/S (GNMSF:OTCMKTS) is 66 out of 100.


toggle

What is the most recent average sentiment for GENMAB A/S (GNMSF:OTCMKTS)?

The most recent sentiment for GENMAB A/S (GNMSF:OTCMKTS) is .


SEC-8K** Filing Available For GENMAB A/S (GNMSF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.